According to research, TRP channels have become drug targets for the treatment of RA as there are multiple TRP channels in rheumatoid arthritis synovial fibroblasts [22–26], including TRPV1, TRPA1, TRPC5, TRPM3, TRPM7, and TRPM8. This evidence concerns the gene TRPM7 and rheumatoid arthritis.